German drugmaker Boehringer Ingelheim will license an experimental inflammatory bowel disease treatment from China's Simcere ...

AI: How does this technological revolution fit with the pharmaceutical regulators who oversee the pharmaceutical sector at ...

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

Chinese drugmaker Qilu Pharmaceutical will be responsible for developing metabolic disease drug candidates from Insilico Medicine under a contract with a total value that "approaches" $120 million, ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...

Americans spent more than $700 billion on prescription medicines last year. However, many of them remain worried about the safety of their medications.

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 million in hand and an impressive roster of executives ready to take the biot | ...

Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

The joint guidance was created to ensure drug developers employ best practices when using AI.

In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...